본문 바로가기

About the Institution

Overview

The Global Training Hub for Biomanufacturing Support Foundation was established following the WHO's designation of Korea as a Global Training Hub for Biomanufacturing.

Centered on the Global Bio Campus, the Foundation develops talent for vaccine and biopharmaceutical manufacturing. Through international cooperation and policy support, we contribute to stronger global health security.

VISION

  • Train

    Training vaccine and biopharmaceutical production personnel in LMIC)

  • Build

    Establishing and operating the GBC

  • Support

    Providing policy support for operating the GTH-B

연혁

History
  • Training Result: 1,015 trainees from 49 countries completed 49 programs
  • Practical Trainings
  • Global Bio Campus practical training on mRNA vaccine manufacturing (26 participants)
  • KOR-IDB training on biopharmaceutical production processes (16 participants)
  • Practical training on biopharmaceutical GMP (17 participants)
  • Practical training on upstream processing for cell-based viral vaccines (14 participants)
  • Sep. 17 Held a side event for the World Bio Summit 2025
2024
  • Training Outcome: 1,007 trainees from 49 countries completed 49 programs
  • Practical Trainings
  • RF training on vaccine production processes (41 participants)
  • Global Bio Campus practical training on mRNA vaccine manufacturing (18 participants)
  • Practical training on upstream processing for cell-based viral vaccines (15 participants)
  • May 21 Established as a nonprofit foundation
  • Sep. 23 Held the Foundation launch ceremony
  • Nov. 12 Held the opening ceremony for the Global Bio Campus (GBC)
2023
  • Training Outcome: 1,187 trainees from 49 countries completed 49 programs
  • Practical Trainings
  • IDB practical training on vaccine and biopharmaceutical production processes for Latin America (40 participants)
  • May 26 Signed a MOU on GTH-B between the WHO and the MOHW
  • June 18 MOHW designated the GBC and 5 network campuses
2022
  • Training Outcome: 754 trainees from 38 countries completed 49 programs
  • Practical Trainings
  • ADB training on vaccine production processes for the Asia Pacific region (59 participants)
  • ADB on-site training for Asian trainees (34 participants)
  • May 26 Signed a MOU on GTH-B between the WHO and the MOHW
  • Feb. 23 WHO designated Korea as GTH-B

Major Projects

  • Education

    -Operating the GBC and coordinating programs with network campuses

    -Education and training for vaccine and biopharmaceutical production personnel from LMICs and Korea

  • Policy & Operation

    -Supporting GTH-B operations, including the WHO and Ministry of Health and Welfare Joint Steering Committee

    -Analyzing policies, laws, and systems, while reflecting stakeholder opinions

  • Funding & Cooperation

    -Securing funding for GTH-B training programs and building a stable foundation for cooperation

    -Building sustainable partnerships with domestic and international institutions

  • Implementations

    -Implementing projects entrusted or supported by the MOHW and related institutions

    -Carrying out revenue-generating activities approved by the MOHW to achieve the Foundation's goals